The CEO has made it pretty clear that SNT are looking for a...

First 87 Last

Share
Profile

Follow
Grainofsand

2,642 Posts.

1912

28/10/24

19:47

Post #: 76341072
Share

Originally posted by ajk92: ↑

Looking at current myelofibrosis treatments, momelotinib passed phase 3 trials and is only offering symptomatic relief. There is nothing disease modifying on the market at all for this cancer, and considering the phase 3 for a drug offering symptomatic relief only required 195 patients, I would assume any phase 2b/phase 3 for SNTs drug would be placed to conduct a much smaller trial.

Also, the treatment was only for 24 weeks with the sole primary endpoint being total symptom score. The FDA may add in another endpoint like spleen volume.

The point im trying to make is, any future development of SNTs drug will be a relatively small trial with not so difficult to meet endpoints typically seen in cancer drug development.

Another major consideration for SNT is how they plan to fund it. This is why the SP over the next year or so is critical. Doing a cap raise at low prices will destroy shareholder value, as it would be quite a substantial raise to fund a phase 2b/phase 3. Otherwise, they may look for a commercial transaction to help fund it.

Expand

The CEO has made it pretty clear that SNT are looking for a partner or buyout to take SNT-5505 to commercialization. They don't expect to do it themselves I would suggest.

SNT Price at posting: 4.7¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: Futures rocket on 'total and complete' Israel-Iran ceasefire | June 24

ASX Market Close: Middle East War rattles investors | June 23, 2025

MPK

Many Peaks accelerating gold hunt in Côte d'Ivoire after assay 'justification'

Markets were expecting Trump to bomb Iran. It's just another new normal

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

First 87 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.7¢		Change -0.002(4.08%)		Mkt cap ! $76.37M

Open	High	Low	Value	Volume
4.9¢	5.0¢	4.6¢	$389.3K	8.169M

Buyers (Bids)

No.	Vol.	Price($)
5	361856	4.6¢

Sellers (Offers)

Price($)	Vol.	No.
4.7¢	34348	2

View Market Depth

No.	Vol.	Price($)
3	315475	0.049
3	370000	0.048
3	275469	0.046
10	877058	0.045
3	334086	0.044

Price($)	Vol.	No.
0.046	50000	1
0.047	50000	1
0.048	301291	2
0.049	124579	1
0.050	1292786	5

Last trade - 16.13pm 23/06/2025 (20 minute delay)

SNT (ASX) Chart

The CEO has made it pretty clear that SNT are looking for a...

Top Stories

ASX Market Open: Futures rocket on 'total and complete' Israel-Iran ceasefire | June 24

ASX Market Close: Middle East War rattles investors | June 23, 2025

Many Peaks accelerating gold hunt in Côte d'Ivoire after assay 'justification'

Markets were expecting Trump to bomb Iran. It's just another new normal

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Buyers (Bids)

Sellers (Offers)